CARRIAGE OF PENICILLIN- AND ERYTHROMYCIN-RESISTANT ORAL STREPTOCOCCI IN CHILDREN WITH ACUTE RESPIRATORY INFECTIONS
Oral streptococci, primarily from Viridans group streptococci, composing oropharyngeal commensal microbiota, are not pathogenic for immunocompetent individuals, although they may cause a severe invasive infection in patients at risk. Moreover, oral streptococci compose a reservoir for resistance determinants against many antimicrobial groups. Hereby, we both analyzed the prevalence of resistant oral streptococci and examined risk factors for their carriage in the children population. The study included children of various age presented at our emergency pediatric department symptoms of acute respiratory infection, who had no received antibiotic treatment for the current infection. Oropharyngeal swabs were plated on Petri dishes, and the colonization rate was calculated as a number of colonies-forming units (CFU) grown on streptococcus selective medium (SSS) without antibiotics, with penicillin (Pen, 1 mg/l) or erythromycin (Ery, 2 mg/l). The proportion of Pen- and Ery-resistant streptococci was calculated as a ratio of CFU value on the antibiotic-containing medium to CFU value on the SSS without any addition. The risk of carriage of resistant streptococci was assessed using odds ratio (OR). In total, in 290 children of a median age of 5.6 (3.4-7.8) years, oropharyngeal swabs were taken. A growth of streptococci on SSS without antibiotics was observed in all 290 specimens. On SSS+Pen and SSS+Ery, a growth was detected in 232 (79.8%) and 268 (92.3%) specimens, respectively. In 224 (77.2%) specimens, both Pen- and Ery-resistant streptococci were present; in 14 (4.8%) no growth on antibiotic-containing plates was found. A median proportion (P25; P75) of Pen- and Ery-resistant streptococci was of 5.8% (0.9%; 16.7%) and 17.5% (6%; 49%), respectively. The colonization rate of Pen-resistant streptococci had a strong reverse correlation with the age (r=-0.222; p<0.001). The risk of carrying Pen-resistant streptococci was higher in children younger of 2 years of age (OR=6; 95%, CI: 0.8-46; p=0.088). Moreover, the use of cephalosporins within the previous year predisposed for Pen-resistant bacteria (OR=8/3; 95% CI: 1.1-62; p=0.015). The prevalence of beta-lactam- and macrolide-resistant oral streptococci in children population is high, especially in younger children. The uptake of a cephalosporin antibiotic with the previous year was a major predisposing factor for the Pen-resistant streptococci carriage
About the authorsMayanskiy Nikolay A.
Baranov A.A., Briko N.I., Namazova-Baranova L.S., Ryapis L.A. Streptococci and pneumococci. [Streptokokki i pnevmokokki]. Rostov n /D: Fenix, 2013. (in Russian)
Malhotra-Kumar S, Lammens C, Martel A, Mallentjer C, Chapelle S, Verhoeven J. et al. Oropharyngeal carriage of macrolide-resistant viridans group streptococci: a prevalence study among healthy adults in Belgium. J Antimicrob Chemother. 2004; 53(2): 271-6.
Simon A, Furtwängler R, Graf N, Laws HJ, Voigt S, Piening B. et al. Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on? GMS Hyg Infect Control. 2016; 11:Doc11. doi: 10.3205/dgkh000271.
Nielsen MJ, Claxton S, Pizer B, Lane S, Cooke RP, Paulus S. et al. Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital. Medicine (Baltimore). 2016; 95(9): 2952.
Beteille E, Guarana M, Nucci M. Infective endocarditis in neutropenic patients with viridans streptococci bacteraemia. Clin Microbiol Infect. 2018; 24(8): 916-7.
Maeda Y, Elborn JS, Parkins MD, Reihill J, Goldsmith CE, Coulter WA et al. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF). J Cyst Fibros. 2011; 10(2): 133-9.
Doern CD, Burnham CA. It’s not easy being green: the viridans group streptococci, with a focus on pediatric clinical manifestations. J Clin Microbiol. 2010; 48(11): 3829-35.
Tan LK, Lacey S, Mandalia S, Melzer M. Hospital-based study of viridans streptococcal bacteraemia in children and adults. J Infect. 2008; 56(2): 103-7.
Balsalobre L, Ferrándiz MJ, Liñares J, Tubau F, de la Campa AG. Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae. Antimicrob Agents Chemother. 2003; 47(7): 2072-81.
Jensen A, Valdórsson O, Frimodt-Møller N, Hollingshead S, Kilian M. Commensal streptococci serve as a reservoir for β-lactam resistance genes in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2015; 59(6): 3529-40.
Bryskier A. Viridans group streptococci: a reservoir of resistant bacteria in oral cavities. Clin Microbiol Infect. 2002; 8(2): 65-9.
Soriano, F. & Rodriguez-Cerrato, V. Pharmacodynamic and kinetic basis for the selection of pneumococcal resistance in the upper respiratory tract. Journal of Antimicrobial Chemotherapy. 2002; 50(Suppl.2): 51-8.
Brenciani A, Tiberi E, Tili E, Mingoia M, Palmieri C, Varaldo PE. et al. Genetic determinants and elements associated with antibiotic resistance in viridans group streptococci. J Antimicrob Chemother. 2014; 69(5): 1197-204.
Ghaffar F, Friedland IR, Katz K, Muniz LS, Smith JL, Davis P. et al. Increased carriage of resistant non-pneumococcal alpha-hemolytic streptococci after antibiotic therapy. J Pediatr. 1999; 135(5): 618-23.
Rozkiewicz D, Daniluk T, Sciepuk M, Zaremba ML, Cylwik-Rokicka D, Luczaj-Cepowicz E. et al. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population. Adv Med Sci. 2006; 51(1): 191-5.
Goldsmith CE, Hara Y, Sato T, Nakajima T, Nakanishi S, Mason C. et al. Comparison of antibiotic susceptibility in viridans group streptococci in low and high antibiotic-prescribing General Practices. J Clin Pharm Ther. 2015; 40(2): 204-7.
Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet. 2007; 369(9560): 482-90.
Lester, S., M. Del Pilar Pla, F. Wang, I. Perez Schaeli, and T. O’Brien. The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, Caracas, Venezuela, and in Qin Pu, China. N. Engl. J. Med. 1990; 323: 285.
O’Brien KL, Bronsdon MA, Dagan R, Yagupsky P, Janco J, Elliott J. et al. Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol. 2001; 39(3): 1021-4.
Ghaffar F, Muniz LS, Katz K, Smith JL, Shouse T, Davis P. et al. Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. Clin Infect Dis. 2002; 34(10): 1301-9.
Pérez-Trallero E, Vicente D, Montes M, Marimon JM, Piñeiro L. High proportion of pharyngeal carriers of commensal streptococci resistant to erythromycin in Spanish adults. J Antimicrob Chemother. 2001; 48(2): 225-9.
Crémieux AC, Muller-Serieys C, Panhard X, Delatour F, Tchimichkian M, Mentre F et al. Emergence of resistance in normal human aerobic commensal flora during telithromycin and amoxicillin-clavulanic acid treatments. Antimicrob Agents Chemother. 2003; 47(6): 2030-5.
Khalil D, Hultin M, Rashid MU, Lund B. Oral microflora and selection of resistance after a single dose of amoxicillin. Clin Microbiol Infect. 2016; 22(11): 949.
Tyrstrup M, Melander E, Hedin K, Beckman A, Mölstad S. Children with respiratory tract infections in Swedish primary care; prevalence of antibiotic resistance in common respiratory tract pathogens and relation to antibiotic consumption. BMC Infect Dis. 2017; 17(1): 603.
Cohen R, Navel M, Grunberg J, Boucherat M, Geslin P, Derriennic M. et al. One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora. Pediatr Infect Dis J. 1999; 18(5): 403-9.
Heikkinen T, Saeed KA, McCormick DP, Baldwin C, Reisner BS, Chonmaitree T. A single intramuscular dose of ceftriaxone changes nasopharyngeal bacterial flora in children with acute otitis media. Acta Paediatr. 2000; 89(11): 1316-21.
Chatterjee A, Modarai M, Naylor NR, Boyd SE, Atun R, Barlow J. et al. Quantifying drivers of antibiotic resistance in humans: a systematic review. Lancet Infect Dis. 2018; 18(12): 368-78.
Bakhit M, Hoffmann T, Scott AM, Beller E, Rathbone J, Del Mar C. Resistance decay in individuals after antibiotic exposure in primary care: a systematic review and meta-analysis. BMC Med. 2018; 16(1): 126. doi: 10.1186/s12916-018-1109-4.
Rachina S.A., Kozlov R.S., Tatochenko V.K., Zarkova L.P., Dudnikova E.V., Sakulina I.B. et al. Analysis of approaches to the use of antibiotics in infections of the upper respiratory tract and LOR organs in children: results of a survey of district pediatricians. Klinicheskaya farmakologiya i terapiya. 2016; 2: 20-7. (In Russian)
Kulichenko T.V., Baibarina E.N., Baranov A.A., Namazova-Baranova L.S., Piskunova S.G., Besedina E.A. et al. Vestnik RAMN. 2016;71(3): 214-23. (In Russian)
- Refbacks are not listed
Контент доступен под лицензией Creative Commons Attribution 3.0 License.